Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their ...

Research has proven frozen blood platelets are safe and effective for use in critically injured patients—a breakthrough dramatically extending their shelf life for transfusions from one week to two ...

1. Lou A, Elnenaei M, Liu E, et al. Evaluation of a novel albumin platelet product (APP) fibrosis index and three ...

Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...

Stage 1 ET is manageable with early intervention, lifestyle changes, and treatments like low-dose aspirin and cytoreductive therapy to reduce clotting risk. Meta: Stage 1 essential thrombocythemia is ...

An experimental drug can help many with a rare autoimmune bleeding condition. More than half of people with immune ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

Wednesday, Lifeline Blood Services honored their committed platelet and plasma donors. Amy Garner, chief compliance and ...